<DOC>
<DOCNO>
EP-0004735
</DOCNO>
<TEXT>
<DATE>
19791017
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/7028 A61K-31/7034 A61P-31/00 C12P-19/00 A61K-31/70 C07H-15/00 C12P-19/46 A61P-31/04 C07H-15/207 
</IPC-CLASSIFICATIONS>
<TITLE>
antibiotics designated as bm 782 alpha 1, bm 782 alpha 2 and bm 782 alpha 1a, process for their preparation and pharmaceutical compositions containing them
</TITLE>
<APPLICANT>
american cyanamid cous<sep>american cyanamid company<sep>american cyanamid companyberdan avenuewayne new jersey 06904us<sep>
</APPLICANT>
<INVENTOR>
borders donald bruceus<sep>fantini amedeo alexanderus <sep>mcgahren william jamesus <sep>tresner homer david us<sep>borders, donald bruce<sep>fantini, amedeo alexander<sep>mcgahren, william james<sep>tresner, homer david<sep>borders, donald bruce13 heatherhill lanesuffern new yorkus<sep>fantini, amedeo alexander2 the glennew city new yorkus<sep>mcgahren, william james64 glenwood avenuedemarest new jerseyus<sep>tresner, homer davidrt. no. 1, munson roadlafarge wisconsinus<sep>
</INVENTOR>
<ABSTRACT>
this invention relates to three new antibiotics which are designated bm782 alpha 1, bm782 alpha 2, and bm782 alpha 1a, respectively, and which are produced in a microbiological fermentation under controlled conditions using a new strain of an undetermined species of the genus nocardia or mutants thereof.  these new antibacterial agents are active against mycobacterium tuberculosis as well as both gram-positive and gram-negative microorganisms and thus are potentially useful for inhibiting the growth of such bacteria and bacilli. 
</ABSTRACT>
</TEXT>
</DOC>
